Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2003-10-29
2008-09-23
Ketter, James S (Department: 1636)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S450000, C435S235100
Reexamination Certificate
active
07427395
ABSTRACT:
An apparatus and a method of remote control which can enable real time operation of a device in home from a terminal device at remote location through a network are provided. A first server communicates with a terminal device through the Internet and generates device control data for controlling the device. A second server communicates with the device in a predetermined manner to acquire and store a specific address of the device, generates transmission data for transmission of the received device control data from the first server to the device based on the specific address, and transmits the transmission data to the device. This allows real time control of the device from the terminal device through the network to be realized.
REFERENCES:
patent: 5077056 (1991-12-01), Bally et al.
patent: 2003/0013195 (2003-01-01), Kaneda
patent: 2003/0038730 (2003-02-01), Imafuku et al.
patent: 2003/0172136 (2003-09-01), Katagawa et al.
patent: 2004/0253272 (2004-12-01), Kaneda
patent: 1170363 (2002-01-01), None
patent: 1416759 (2004-05-01), None
patent: 1416760 (2004-05-01), None
patent: 2001/145140 (2001-05-01), None
patent: 2001-286282 (2001-10-01), None
patent: 2002-65278 (2002-03-01), None
patent: 2002-065278 (2002-03-01), None
patent: 2003-52082 (2003-02-01), None
patent: 2003-52093 (2003-02-01), None
patent: 3445986 (2003-06-01), None
patent: 97/04748 (1997-02-01), None
patent: WO 97/04748 (1997-02-01), None
patent: 01/57201 (2001-08-01), None
patent: WO 01/57204 (2001-08-01), None
patent: 03/14338 (2003-02-01), None
patent: WO 03/014338 (2003-02-01), None
Kumar et al., FEBS Letters, vol. 391, 1996, pp. 17-20.
English Language Abstract of JP 2001/145140. (2001).
English Language Abstract of JP 2003-52093. (2003).
English Language Abstract of JP 2003-52082. (2003).
Howell et al. “Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam technology” Cancer J. 7:219-227 (2001).
Kaneda et al., “Hemagglutinating virus of Japan (HVG) envelope vector as a versatile gene delivery system” Mol. Ther. 6: 219-226 (2002).
Kaneda, “Virosomes, evolution of the liposome as a targeted drug delivery system” Adv. Drugs Delivery Rev. 43:197-205 (2000).
Tanaka et al., “NEW Yakurigaku” pp. 557-566 (1997) and summary in English.
International Search Report of PCT/JP03/13860 (2004).
Y. Kaneda et al., “Hemagglutinating Virus of Japan (HVG) Envelope Vector as a Versatile Gene Delivery System”, Moelcular Therapy, Aug. 2002, vol. 6, No. 2, pp. 219-226.
Y. Kaneda, “Virosomes, evolution of the liposome as a targeted drug delivety system”, Advanced Drug Delivery Reviews, 2000, vol. 43, pp. 197-205.
C. Tanaka et al., “NEW Yakurigaku”, Aug. 1, 1997, pp. 557-566.
International Search Report of PCT/JP03/13860 mailed Feb. 10, 2004.
Kaneda Yasufumi
Kotani Hitoshi
Yamamoto Seiji
Anges MG Inc.
Genomidea Inc.
Ketter James S
Nixon & Vanderhye P.C.
LandOfFree
Chemotherapeutic agent-incorporated pharmaceutical preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemotherapeutic agent-incorporated pharmaceutical preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemotherapeutic agent-incorporated pharmaceutical preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3982508